Aiken Bones Ltd SC312202 false 2023-01-01 2023-12-31 2023-12-31 The principal activity of the company is has been provision of osteopathy services to the public Digita Accounts Production Advanced 6.30.9574.0 true true SC312202 2023-01-01 2023-12-31 SC312202 2023-12-31 SC312202 bus:OrdinaryShareClass1 2023-12-31 SC312202 core:CurrentFinancialInstruments 2023-12-31 SC312202 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 SC312202 core:Non-currentFinancialInstruments 2023-12-31 SC312202 core:Non-currentFinancialInstruments core:AfterOneYear 2023-12-31 SC312202 core:Goodwill 2023-12-31 SC312202 core:FurnitureFittingsToolsEquipment 2023-12-31 SC312202 bus:SmallEntities 2023-01-01 2023-12-31 SC312202 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 SC312202 bus:FullAccounts 2023-01-01 2023-12-31 SC312202 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 SC312202 bus:RegisteredOffice 2023-01-01 2023-12-31 SC312202 bus:Director1 2023-01-01 2023-12-31 SC312202 bus:OrdinaryShareClass1 2023-01-01 2023-12-31 SC312202 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 SC312202 bus:Agent1 2023-01-01 2023-12-31 SC312202 core:Goodwill 2023-01-01 2023-12-31 SC312202 core:FurnitureFittingsToolsEquipment 2023-01-01 2023-12-31 SC312202 countries:Scotland 2023-01-01 2023-12-31 SC312202 2022-12-31 SC312202 core:Goodwill 2022-12-31 SC312202 core:FurnitureFittingsToolsEquipment 2022-12-31 SC312202 2022-01-01 2022-12-31 SC312202 2022-12-31 SC312202 bus:OrdinaryShareClass1 2022-12-31 SC312202 core:CurrentFinancialInstruments 2022-12-31 SC312202 core:CurrentFinancialInstruments core:WithinOneYear 2022-12-31 SC312202 core:Non-currentFinancialInstruments 2022-12-31 SC312202 core:Non-currentFinancialInstruments core:AfterOneYear 2022-12-31 SC312202 core:Goodwill 2022-12-31 SC312202 core:FurnitureFittingsToolsEquipment 2022-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: SC312202

image-name

Aiken Bones Ltd

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2023

 

Aiken Bones Ltd

Contents

Company Information

1

Accountants' Report

2

Balance Sheet

3 to 4

Notes to the Financial Statements

5 to 10

 

Aiken Bones Ltd

Company Information

Directors

Michael Alex Aiken

Registered office

Glasgow Osteopathic Centre
30/32 Battlefield Road
Glasgow
G42 9QH

Bankers

Royal Bank of Scotland plc
53a High Street
Dunblane
FK15 0EQ

Accountants

RGA Scotland Limited
Chartered Accountants
Orchardlea
Callander
FK17 8BG

 

Chartered Accountants' Report to the Director on the Preparation of the Unaudited Statutory Accounts of
Aiken Bones Ltd
for the Year Ended 31 December 2023

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Aiken Bones Ltd for the year ended 31 December 2023 as set out on pages 3 to 10 from the company's accounting records and from information and explanations you have given us.
 

This report is made solely to the Board of Directors of Aiken Bones Ltd , as a body, in accordance with the terms of our engagement. Our work has been undertaken solely to prepare for your approval the accounts of Aiken Bones Ltd and state those matters that we have agreed to state to the Board of Directors of Aiken Bones Ltd, as a body, in this report.

This is in accordance with the requirements of such bodies as the ACCA, ICAS and ICAEW, to the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Aiken Bones Ltd and its Board of Directors as a body for our work or for this report.
 

It is your duty to ensure that Aiken Bones Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Aiken Bones Ltd. You consider that Aiken Bones Ltd is exempt from the statutory audit requirement for the year.
 

We have not been instructed to carry out an audit or a review of the accounts of Aiken Bones Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

image-name

....................................................................

RGA Scotland Limited
Chartered Accountants
Orchardlea
Callander
FK17 8BG


 

10 July 2024

 

Aiken Bones Ltd

(Registration number: SC312202)
Balance Sheet as at 31 December 2023

Note

2023
£

2022
£

Fixed assets

 

Intangible assets

5

9,000

9,000

Tangible assets

6

5,500

4,797

 

14,500

13,797

Current assets

 

Stocks

7

300

300

Debtors

8

707

378

Cash at bank and in hand

 

50,074

35,742

 

51,081

36,420

Creditors: Amounts falling due within one year

9

(20,866)

(14,622)

Net current assets

 

30,215

21,798

Total assets less current liabilities

 

44,715

35,595

Creditors: Amounts falling due after more than one year

9

(7,627)

(10,667)

Provisions for liabilities

(1,045)

(911)

Net assets

 

36,043

24,017

Capital and reserves

 

Called up share capital

10

100

100

Retained earnings

35,943

23,917

Shareholders' funds

 

36,043

24,017

 

Aiken Bones Ltd

(Registration number: SC312202)
Balance Sheet as at 31 December 2023

For the financial year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 10 July 2024
 

.........................................
Michael Alex Aiken
Director

 

Aiken Bones Ltd

Notes to the Financial Statements for the Year Ended 31 December 2023

1

General information

The company is a private company limited by share capital, incorporated in Scotland.

The address of its registered office is:
Glasgow Osteopathic Centre
30/32 Battlefield Road
Glasgow
G42 9QH

These financial statements were authorised for issue by the director on 10 July 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

 

Aiken Bones Ltd

Notes to the Financial Statements for the Year Ended 31 December 2023

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures, fittings, equipment

20-50% p.a reducing balance basis

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

no further amortisation considered necessary

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

 

Aiken Bones Ltd

Notes to the Financial Statements for the Year Ended 31 December 2023

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 5 (2022 - 5).

4

Profit before tax

Arrived at after charging/(crediting)

2023
£

2022
£

Depreciation expense

1,262

1,000

 

Aiken Bones Ltd

Notes to the Financial Statements for the Year Ended 31 December 2023

5

Intangible assets

Goodwill
 £

Total
£

Cost or valuation

At 1 January 2023

21,667

21,667

At 31 December 2023

21,667

21,667

Amortisation

At 1 January 2023

12,667

12,667

At 31 December 2023

12,667

12,667

Carrying amount

At 31 December 2023

9,000

9,000

At 31 December 2022

9,000

9,000

6

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 January 2023

36,813

36,813

Additions

1,965

1,965

At 31 December 2023

38,778

38,778

Depreciation

At 1 January 2023

32,016

32,016

Charge for the year

1,262

1,262

At 31 December 2023

33,278

33,278

Carrying amount

At 31 December 2023

5,500

5,500

At 31 December 2022

4,797

4,797

 

Aiken Bones Ltd

Notes to the Financial Statements for the Year Ended 31 December 2023

7

Stocks

2023
£

2022
£

Finished goods and goods for resale

300

301

Stock for sale and business use

-

(1)

300

300

8

Debtors

Current

2023
£

2022
£

Prepayments

707

378

 

707

378

9

Creditors

Creditors: amounts falling due within one year

Note

2023
£

2022
£

Due within one year

 

Loans and borrowings

11

4,230

3,429

Taxation and social security

 

11,367

9,684

Accruals and deferred income

 

2,618

1,427

Other creditors

 

2,651

82

 

20,866

14,622

10

Share capital

Allotted, called up and fully paid shares

 

2023

2022

 

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100

         
 

Aiken Bones Ltd

Notes to the Financial Statements for the Year Ended 31 December 2023

11

Loans and borrowings

2023
£

2022
£

Non-current loans and borrowings

Bank borrowings

7,627

10,667

2023
£

2022
£

Current loans and borrowings

Bank borrowings

3,200

3,200

Director current account

1,030

229

4,230

3,429